ReviewLeukemia2019
Rethinking clinical trial endpoints in myelodysplastic syndromes.
Mikkael A Sekeres et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this paperpooled itcites it
ReviewLeukemia2019
Mikkael A Sekeres et al.PubMed ↗Publisher ↗
No numbers read from the abstract.